The protocols were described in our previous reports [19 (link)]. The primary antibodies used were as follows: anti-FLAG, anti-AKT1, anti-p-AKT1, anti-mTOR, anti-p-mTOR (CST), and anti-GAPDH and anti-PDZK1 (Proteintech, USA).
Free full text: Click here